Related Experiment Video

Updated: Aug 29, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Cyclooxygenase inhibition and mechanisms of colorectal cancer prevention

Timothy A Chan1

  • 1Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, 1650 Orleans Street, Baltimore, MD 21231, USA. tim@jhmi.edu

Current Cancer Drug Targets
|December 20, 2003
PubMed

Insights

Nonsteroidal anti-inflammatory drugs (NSAIDs) show promise in preventing colon cancer through both cyclooxygenase (COX) inhibition and other pathways. These findings highlight NSAIDs as potential agents for colorectal cancer prevention.

Area of Science:

  • Oncology
  • Pharmacology
  • Gastroenterology

Background:

  • Colorectal cancer is a significant global health issue with high mortality rates.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors demonstrate anti-tumorigenic properties against colorectal cancer.
  • Epidemiological and animal studies support the chemopreventive potential of NSAIDs in colorectal cancer.

Purpose of the Study:

  • To investigate the mechanisms by which NSAIDs inhibit colorectal tumorigenesis.
  • To explore both cyclooxygenase (COX)-dependent and COX-independent pathways involved in NSAID chemoprevention.

Main Methods:

  • Review of epidemiological studies on NSAID use and colorectal cancer incidence.
  • Analysis of animal model investigations into NSAID efficacy.
  • Examination of biochemical pathways, including COX inhibition and alternative mechanisms.

Main Results:

  • NSAIDs, including celecoxib and rofecoxib, exhibit significant anti-colorectal cancer properties.
  • NSAID chemopreventive effects are partly attributed to the inhibition of cyclooxygenase (COX) enzymes.
  • Emerging evidence suggests NSAIDs may also act through COX-independent mechanisms.

Conclusions:

  • NSAIDs possess dual mechanisms of action, involving both COX-dependent and COX-independent pathways, for colorectal cancer chemoprevention.
  • The combined effects likely contribute to the observed anti-tumorigenic activity of NSAIDs.
  • Further research into these mechanisms could optimize NSAID-based strategies for colorectal cancer prevention.

More Related Videos

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine06:24

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.